Adaptor proteins and Ras synergistically regulate IL-1-induced ADAMTS-4 expression in human chondrocytes

Rasheed Ahmad1, Judith Sylvester, Mushtaq Ahmad

  • 1Department of Medicine, University of Montreal and Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Notre-Dame Hospital, Montreal, Quebec, Canada.

Insights

Interleukin-1 beta (IL-1beta) upregulates aggrecanase-1 (ADAMTS-4) in cartilage via MyD88, IRAK1, TRAF6, and Ras signaling. Combined inhibition of Ras and adaptor proteins may treat arthritis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Aggrecanases, including aggrecanase-1 (ADAMTS-4), are key enzymes in cartilage degradation.
  • Interleukin-1 beta (IL-1beta) is a pro-inflammatory cytokine implicated in cartilage breakdown.
  • The signaling pathways mediating IL-1beta-induced ADAMTS-4 expression are not fully understood.

Purpose of the Study:

  • To elucidate the roles of adaptor proteins MyD88, IRAK1, and TRAF6 in IL-1beta-induced ADAMTS-4 regulation.
  • To investigate the involvement of Ras and reactive oxygen species (ROS) in this signaling pathway.
  • To explore potential therapeutic strategies for arthritis by targeting these pathways.

Main Methods:

  • Small interfering RNA (siRNA)-mediated knockdown of MyD88, IRAK1, TRAF6, and Ras in chondrocytes.
  • Treatment with IL-1beta and measurement of ADAMTS-4 expression.
  • Inhibition of ROS using antioxidants.
  • Assessment of downstream signaling molecules, including IkappaB kinase (IKK) and NF-kappaB activation.

Main Results:

  • IL-1beta-induced ADAMTS-4 upregulation requires MyD88, IRAK1, and TRAF6.
  • Ras and ROS significantly contribute to IL-1beta-induced ADAMTS-4 expression.
  • Combined knockdown of Ras and adaptor proteins potently inhibited ADAMTS-4 induction and NF-kappaB activation.
  • IL-1beta-induced activation of IKK, IkappaBalpha, and NF-kappaB was reduced in cells lacking these signaling components.

Conclusions:

  • Ras, ROS, and adaptor proteins (MyD88, IRAK1, TRAF6) synergistically mediate IL-1beta-induced ADAMTS-4 regulation.
  • Combined inhibition of Ras and adaptor proteins offers a promising therapeutic approach for controlling ADAMTS-4 expression in inflammatory joint diseases like arthritis.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...